Delivery Order SPE2DB20D1051-SPE2DB25FD9MM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ivabradine HCL 7.5 mg tablets (60-count units) under a firm fixed-price contract valued at $12,159.83. The award was made on September 24, 2025, with an ultimate completion date of September 25, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Ivabradine HCL 5 mg tablets (60-count units) with a ceiling value of $19,104.45. This is a firm fixed-price, non-set-aside delivery order that will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 11, 2025. The contract represents a routine pharmaceutical procurement supporting federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,718.01 to AmerisourceBergen Drug Corp for the supply of Ivabradine HCl 5 mg tablets (60-count package) on September 11, 2025, with an ultimate completion date of September 12, 2025. This delivery order represents a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award is a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, for the supply of Ivabradine HCL 5 mg tablets in a 60-count quantity. The contract, executed on September 26, 2025, carries a ceiling value of $19,626.23 and is structured as a firm fixed-price delivery order with no set-aside designation. Performance will be completed by September 29, 2025, reflecting the expedited nature of this...
- The Defense Logistics Agency awarded a $3,992.21 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Ivabradine HCl 5 mg tablets (60-count). This non-set-aside contract is scheduled for completion by August 1, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Ivabradine HCL 5 mg tablets (60-count units) with a ceiling value of $3,598.88. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for completion by September 11, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,730.65 to AmerisourceBergen Drug Corp for Ivabrine HCL 5 mg tablets (60-count) on July 21, 2025, with completion scheduled for July 22, 2025. The contract is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate Office location in the same city. This award represents a...
- This federal contract award to Amerisourcebergen Drug Corp was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of Ivabradine HCl 5mg tablets. The contract is a $1,718.01 firm fixed price delivery order, with an ultimate completion date of August 22, 2024. The award date was August 21, 2024, and there was no set-aside designation used. This order is likely part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $9,188.29 to AmerisourceBergen Drug Corp for the supply of Corlanor (ivabradine) 5 mg tablets in a quantity of 60 units. This competitively awarded, firm fixed-price delivery order was issued on August 8, 2025, with an ultimate completion date of August 11, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $8,002.50 to AmerisourceBergen Drug Corp for the supply of Corlanor (ivabradine) 5 mg tablets in a 60-count quantity. The contract, awarded September 10, 2025, with completion targeted for September 11, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB20D1051Indefinite Delivery Contract
- SPE2DB20D1051-SPE2DB25FD9MMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $15,173.50 to AmerisourceBergen Drug Corp for the supply of Ivabradine HCl 5 mg tablets (60-count units) on September 16, 2025, with completion expected by September 17, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded transaction under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. The delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Ivabradine is a specialized cardiac medication used to reduce heart rate in patients with heart failure, reflecting the company's role in supplying therapeutic medications across multiple clinical domains to support Defense Health Agency operations and other federal healthcare systems. As a major pharmaceutical vendor, AmerisourceBergen maintains an extensive portfolio of competitively awarded federal contracts with DLA, demonstrating sustained capability to fulfill diverse medical supply requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.2k | 9/16/25 |